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Stimulation of thymus-derived lymphocytes by antigens or mitogens induces
the release of soluble factors which influence the development of antibody-pro-
ducing cells during a humoral immune response. Such accessory factors may be
antigen specific (1-4) or nonspecific (1, 2, 5-7) and may act as amplifiers (1-7) or
suppressors (1, 8-10) of the immune response, thus illustrating the distinctive
role of activated T cells in the modulation ofB-cell responses to antigen (11, 12) .
Recently, Fridman and Golstein (13) described a factor from alloantigen-
activated T cells which specifically binds to the Fc fragment of IgG (immuno-
globulin-binding factor, IBF) and blocks complement (C) activation by IgG (14).
Since IBF is synthesized by T cells (13) and since IgG is known to participate in
the regulation of B-cell responses (15), it is interesting to speculate on whether
IBF might interfere with antibody synthesis. In the present communication, we
describe the suppressive effect of IBF on the synthesis of antibodies to
T-dependent and T-independent antigens in vitro and submit that IBF may be a
soluble mediator of suppressor T cells.
Materials and Methods
Preparation of IBF.
￿
Activated T cells (ATC) were prepared from spleens of 12- to 16-wk old
BALB/c mice which had been irradiated with 700 R and injected intravenously with 108 C3H (4- to
8-wk old) thymus cells 5 days before (16). Supernates containing IBF were collected after 2 h of
incubation of 2 x 108 ATC which had been separated from non-T cells by removing phagocytic and
adherent cells with the aid of carbonyl iron and apowerful magnet, as described in aprevious paper
(13) . From these crude supernates (S-ATC) IBF was isolated on affinity chromatography columns.`
Briefly, Sepharose 4B beads were activated with cyanogen bromide and coupled with rabbit IgG at a
concentration of 5-10 mg/ml. S-ATC at 0°C was then introduced into the columns, which were
washed thoroughly with 0.02 M phosphate buffer at pH 7.0. Thereafter, the fixed IBFwaseluted with
glycine buffer at pH 2.8. Column eluates and effluents were dialyzed against phosphate-buffered
saline and concentrated to the starting volume. Moreover, columnscoupled with rabbit IgMor Fab',
fragment of IgG were used to obtain control preparations. Rabbit Ig subgroups or Ig fragments were
prepared as previously described (13) .
Measurement of IBF activity.
￿
IBF activity was tested by measuring the inhibition of C-induced
hemolysis in sheep erythrocytes (SRBC) sensitized with rabbit IgG antibody (reference 13 and
footnote 1) . The unit referred to in the text is the amount causing 50% inhibition of lysis.
Spleen Cell Cultures . 10' spleen cells from 8- to 12-wk old (C57BL x DBA/2)F, mice were
cultured in 12 x 75 mm Falcon plastic tubes (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) in 1
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ml of Medium RPMI 1640 (Microbiological Associates, Bethesda, Md.) supplemented with 5% fetal
calf serum (Rehatuin, Reheis Chemical Co., Chicago, Ill.) and antibiotics (penicillin, streptomycin,
5,000 U each) in a COZ incubator (10% CO, in air). No nutritive cocktail was added. Cultures were
stimulated with 3 x 106 SRBC of 10-2 lug/ml of dinitrophenylated aminoethyldextran (DNP-AE-
DEX) (3) . To some cultures graded doses of IBFor control preparations (1-100 ul/ml) were added at
different times of incubation.
Plaque Assay .
￿
Direct plaque-forming cells (PFC) were assayed by the local hemolysis technique
in liquid medium (17). To detect anti-DNP responses, horse erythrocytes coated with TNPwere used
as indicator cells (18).
Results and Discussion
Addition of graded amounts of crude S-ATC or purified IBF to antigen-
stimulated spleen cell cultures at initiation of the response significantly
suppressed the direct PFC response to SRBC and to the T-independent antigen
DNP-AE-DEX (Fig. 1) . The inhibitory capacity of both preparations was
essentially correlated to their contents of IBF, as determined by their ability to
inhibit C-dependent hemolysis, despite the fact that the crude preparations
contained 50-60 times more protein than the purified preparations . Thus,
purification based on the affinity of IBF for IgG resulted in a clear-cut increase of
specific biological activity. However, in no case could the PFC response be totally
abolished, suggesting that part of the 19S antibody precursor cells might escape
or withstand the effect of IBF. Furthermore, suppression of PFC was not
correlated with a decrease in the number of viable cells recovered.
The assumption that IBF was the suppressor is further strengthened by the
data shown in Fig. 2. Affinity columns coated with IgM or Fab', fragment of IgG,
on which IBF was not retained, were also unable to eliminate the soluble
inhibitor, whereas effluents from IgG-coated columns, which bind IBF, lost their
suppressive properties. If' IBF was recycled on IgG-coated columns, both its
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FIG. 1. Effect of IBF (units per milliliter, added together with antigen) on direct PFC
formation in spleen cell cultures. Response to SRBC : " IN ", cultures treated with crude
supernate of ATC; and " - ", cultures treated with purified IBF. Response to DNP-AE-
DEX: A - A, cultures treated with purified IBF. Each plot represents the mean (t standard
deviation) of the PFC counts from five to eight experiments. Plaque responses in control
cultures varied between 751-2,613 PFC/106 cells against SRBC (day 5) and 279-765 PFC/106
cells against DNP-AE-DEX (day 3) .GISLER AND FRIDMAN
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FIG. 2. Effect ofdifferent preparations from various types of affinity chromatography column
on direct PFC formation against SRBC in spleen cell cultures. All preparations were added at
initiation. Numbers at various points on the curves indicate units ofIBF. " - ", effluent from
IgG-coated column ; " - ", effluent from Fab' z-coated column ; " - ", effluent from
IgM-coated column; "- ", effluent from IgG-coated column on which IBFwasrecycled; O -
O, effluent from IgM-coated column on which IBF wasrecycled; and "M", purified IBF.
ability to block C-dependent hemolysis and its suppressive effect on the PFC
response disappeared. Finally, IBF recycled on IgM-coated columns did not
bind, and the effluent remained fully inhibitory.
When IBF was added at the start of induction its suppressive effect only
became apparent at the peak of the response (R. H. Gisler and W. H. Fridman,
unpublished observation) . It therefore seems questionable whether it had any
effect at all on the induction of the response . From Table I it is clearthat neither
pretreatment of the cells nor the late addition of IBF (96 h) interfered with the
generation of PFC. However, IBF was active when added between initiation and
72 h and displayed maximum inhibitory capacity when added at 72 h. In
conclusion, the critical events which finally cause suppression of the PFC
response may occur during terminal differentiation of antibody-forming cell
precursors. It rllsy be pertinent .in this context that suppressor T cells have been
found to be most active when added to stimulated spleen cell cultures 48 h after
TABLE I
Effect of IBF (0.4 Ulml) Added at Different Times on the Response of Spleen Cell
Cultures to SRBC
IBFadded before (-), together with (0h), or after (+) antigen
-6h
￿
0 h
￿
+24h
￿
+48h
￿
+72h
￿
+96h
PFC, %of controls*
￿
108.5 f4.4
￿
51 .8 t 13.6
￿
59.7 f 10.5
￿
36.0+9.8
￿
13.5 t 11 .3
￿
93.2 f 6.4
* Arithmetic means (t standard deviation) of PFC counts (day 5) from seven independent culture experiments.
Plaque responses in control cultures varied between 806-3,094 PFC/10e.510
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initiation (19) . Similarly, Schimpl and co-workers (5) have associated the
opposite phenomenon, namely enhancement of PFC generation by T-cell-replac-
ing factor, with the late phase of terminal differentiation of activated clones . In
our case, however, a possible interference with clone expansion cannot, as yet, be
fully excluded . Alternatively, the observed suppression of 19S PFC could be due
to an IBF-induced switch from the generation of 19S PFC to 7S PFC or to
diversion from active antibody synthesis into memory cell pools.
It has already been demonstrated by other workers that soluble inhibitors of
humoral antibody synthesis are secreted by ATC (8, 9) or by'T-cell lymphomas
(10). Since these factors are largely undefined, it is difficult to compare them with
IBF. However, in contrast to IBF, the nonspecific inhibitors described by Feld-
mann (9) and Stocker et al. (10) seem to act only on T-dependent responses. Fur-
thermore, unlike "soluble immune response suppressor" (8), IBF acts best at the
late phase of the response.
IBF which is defined by its specificity for the Fc fragment of IgG is produced by
ATC (13), some of which are known to bear Fc receptors (13, 20, 21). Recent data
suggest that IBF may even be identical with Fc receptors released from ATC. 2 If
this proves correct, then according to the foregoing data, the Fc receptor of T cells
would appear to have an important part in the regulation of humoral antibody
synthesis.
Summary
Alloantigen-activated mouse T cells secrete a factor which binds to the Fc
fragment of IgG and blocks complement (C) activation by IgG (immunoglobulin-
binding factor, IBF) . IBF was found to suppress the direct plaque-forming cell
(PFC) response of mouse spleen cell cultures to sheep erythrocytes and to
dinitrophenylated aminoethyldextran (T-independent antigen) . Purification of
IBF by affinity chromatography on IgG-coated Sepharose columns led to an
increase of the suppressive capacity of the preparations. In samples from various
types of affinity columns (coated with IgG, IgM, or Fab' 2 from IgG) the factor
responsible for inhibiting the PFC response could not be dissociated from that
responsible for the inhibitory activity of IBF on C-dependent hemolysis. No
effect was seen when cultures were pretreated for 6 h, or when IBF was added up
to 96 h after initiation . On the other hand, IBF was most suppressivewhen added
at 72 h. These data are compatible with theview that IBF is a soluble mediator of
suppressor T cells which may interfere with terminal differentiation of antibody-
forming cell precursors.
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